Latest return on equity
BioNexus Gene Lab Return on equity
BioNexus Gene Lab (BGLC) return on equity with its verified observation date.
Direct answer
BioNexus Gene Lab's return on equity is -33.66%.
The verified market snapshot reports -33.66%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked August 24, 2026.
Get free BioNexus Gene Lab email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -33.66%
Explore related company data
View BioNexus Gene Lab's market capitalizationView BioNexus Gene Lab's price-to-book ratioView BioNexus Gene Lab's 52-week price rangeView BioNexus Gene Lab's revenue growthView BioNexus Gene Lab's profit marginView BioNexus Gene Lab's debt-to-equity ratioView all BioNexus Gene Lab key metricsReturn to BioNexus Gene Lab profile